|
- Bausch + Lomb Careers
X You are now leaving the Bausch + Lomb Website The website you are about to visit is not affiliated with Bausch + Lomb Incorporated Bausch + Lomb is not responsible for the content, format, maintenance, or policies of the website you are about to enter and does not monitor non-affiliated websites for accuracy
- SEC Filings | Bausch + Lomb Corporation
©2025 Bausch + Lomb MTB 0115 USA 21 All Information and m aterials on this site pertain to the U S only, unless otherwise indicated
- Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink . . .
Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States Jun 04 2025 Blink Nourish and Blink Boost are now available at most U S national retailers, including Walmart, Target, CVS, Walgreens and Amazon; Blink Nourish is the first and only vitamin-enriched preservative-free eye drop designed to replenish and rebalance the tear film
- Bausch + Lomb Commercial and Manufacturing Locations
COMMERCIAL LOCATIONS Argentina Bausch Lomb Argentina SRL Av del Libertador 174 Vicente Lopez B1638BEN PCIA Buenos Aires Argentina Teléfono: +54 11 4718-4200
- Bausch + Lomb Acquires AcuFocus, Inc.
Bausch + Lomb Acquires AcuFocus, Inc Jan 17 2023 Acquisition Will Enhance Bausch + Lomb’s Surgical Portfolio with IC-8 ® Apthera ™ Intraocular Lens VAUGHAN, Ontario IRVINE, Calif --(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and AcuFocus, Inc (“AcuFocus
- URGENT PRODUCT RECALL
22 1 5-NTEM-7 Revision: 1 Page 1 of 7 Bausch Lomb Incorporated 21 N Park Place Boulevard Clearwater, FL 33759 URGENT MEDICAL DEVICE RECALL URGENT FIELD SAFETY NOTICE
- Bausch + Lomb Announces First-Quarter 2025 Results
Bausch + Lomb Announces First-Quarter 2025 Results Apr 30 2025 Revenue of $1 137 Billion; GAAP Net Loss Attributable to Bausch + Lomb Corporation of $212 Million; Adjusted EBITDA Excluding Acquired IPR D (non-GAAP) 1 of $126 Million Revenue Grew 3% as Reported and 5% on a Constant Currency 1 Basis Compared to the First Quarter of 2024; Updating Full-Year 2025 Guidance to Reflect Estimated One
- Bausch + Lomb Official Home Page
Bausch + Lomb is one of the world's largest suppliers of contact lenses, lens care products, prescription pharmaceuticals, intraocular lenses and other eye surgery products
|
|
|